• Aucun résultat trouvé

Bigot Culty , E. Brassart , J. Riou , A.R. Azzouzi ,P. T. Segalen , S. Lebdai , P. Panayotopoulos ,T. Évaluation du drainage par sonde double J après urétéroscopie pour maladielithiasique for urolithiasis Double J stenting evaluation afterureteroscopy

N/A
N/A
Protected

Academic year: 2022

Partager "Bigot Culty , E. Brassart , J. Riou , A.R. Azzouzi ,P. T. Segalen , S. Lebdai , P. Panayotopoulos ,T. Évaluation du drainage par sonde double J après urétéroscopie pour maladielithiasique for urolithiasis Double J stenting evaluation afterureteroscopy"

Copied!
7
0
0

Texte intégral

(1)

Disponibleenlignesur

ScienceDirect

www.sciencedirect.com

ORIGINAL ARTICLE

Double J stenting evaluation after ureteroscopy for urolithiasis

Évaluation du drainage par sonde double J après urétéroscopie pour maladie lithiasique

T. Segalen

a,∗

, S. Lebdai

a

, P. Panayotopoulos

a

, T. Culty

a

, E. Brassart

a

, J. Riou

b

, A.R. Azzouzi

a

, P. Bigot

a

aDepartmentofurology,Angersuniversityhospital,4,rueLarrey,49000Angers,France

bMINT,universitéd’Angers,InsermU1066,CNRS6021,universitéBretagneLoire,49000 Angerscedex,France

Received3March2019;accepted7August2019 Availableonline7September2019

KEYWORDS Renalcalculi;

Ureteroscopy;

Ureteralcalculi;

Ureteralstent;

Urolithiasis

Summary

Objectives.—Duringureteroscopyforurolithiasis,postoperativeureteraldrainagewithdouble Jstentisfrequentlyused.Itmayreduceacutepostoperativepainandlateureteralstenosis.

Double Jstent canhave negativeimpact onlifequality. After uncomplicatedintervention, doubleJstentisnotmandatory.Objectiveofourstudywastoevaluatepainandcomplications afterureteroscopywithorwithoutstent.

Methods.—WeretrospectivelyanalyzedureteroscopyperformedbetweenMay2014andJan- uary2017.InterventionswerecomparedregardingureteraldrainagewithdoubleJstentornot.

Ourprimaryoutcomewasearlypostoperativepainevaluatedwithanoralpainscaleform1to 10ondayoneafterintervention.Clinicalcharacteristics, per-andpostoperativedata were collected.Wealsolookedforrisksfactorsofcomplications.

Results.—Threehundredandsixty-sixinterventionswereincluded,259(70.8%)withand107 (29.2%)withoutdoubleJstent.Stoneburdenwas higherinstented group(18.3 vs9.4mm, P<0.0001).Patientswithoutpostoperativestentshadmoreureteralpreparationwithdouble Jstent(78.5%vs62.5%,P=0.0032)andhadmoreambulatoryinterventions(75.7%vs52.5%, P<0.0001).Postoperativepainwasnotdifferent(22%vs17.75%,P=0.398).Complicationrate wassimilar (29%vs 20.5%,P=0.1181),sowasrehospitalizationrate(0.8%vs0.9%, P=1).In multivariateanalysis,complicationsfactorswereunpreparedureter,experiencedsurgeonsand accesssheath.

Correspondingauthor.

E-mailaddresses:Tristan.segalen@gmail.com,tristan0503@hotmail.com(T.Segalen).

https://doi.org/10.1016/j.purol.2019.08.266 1166-7087/©2019PublishedbyElsevierMassonSAS.

(2)

Conclusion.—Notstentingafterureteroscopydonotincreasepainorcomplications.Stenting shouldnotbeusedafteruncomplicatedinterventionsforcentimetricstones.

Levelofevidence.—4.

©2019PublishedbyElsevierMassonSAS.

MOTSCLÉS Calculrénal; Urétéroscopie; Calculurétéral; Stenturétéral; Maladielithiasique

Résumé

Objectifs.—Lors des urétéroscopies pour fragmentation de calculs, le drainage urétéral postopératoire parsonde double J (SDJ) est fréquent. Celui-ci permettraitde diminuer le risquedecoliquenéphrétiqueetdesténoseurétérale.Ilexistecependantdescomplications liéesauxSDJcommelesdouleurslombairesetdessymptômesurinaires.Encasd’intervention noncompliquée,l’utilisationd’unesondedoubleJn’estdoncpasrecommandée.L’objectifde notreétudeétaitd’évaluerl’intérêtdudrainageurétéralparSDJenfind’URSsurladouleur postopératoireprécoceetlescomplications.

Méthodes.—Nousavonsanalysérétrospectivement,touteslesurétéroscopiesréaliséesentre mai 2014 et janvier 2017. Nous avons comparé les patients ayant été drainés par SDJ et ceuxn’ayantpaseudedrainageurétéral.Le critèreprincipaldejugement étaitladouleur postopératoireprécoceévaluéeparuneéchelleoraledeladouleurcotéede1à10,lelende- maindel’intervention.Nousavonsmesurélescaractéristiquescliniques,lesdonnéespéri-et postopératoiresdespatientsavecetsansSDJpostopératoire.Nousavonségalementrecherché lesfacteursderisquedecomplications.

Résultats.—Nousavonsinclus366interventionsdont259(70,8%)avecet107(29,2%)sans SDJ.Les calculsétaientsignificativement plusvolumineux(18,3 vs9,4mm,p<0,0001)dans legroupeSDJ.LespatientssansSDJavaienteuplusdeSDJpréopératoires(78,5%vs62,5%, p=0,0032)etavaiteuplussouventunechirurgieambulatoire(75,7%vs52,5%,p<0,0001).

Concernantladouleurpostopératoire,iln’yavaitpasdedifférenceentreles2groupes(22% vs17,75%;p=0,398).Letauxdecomplicationpostopératoireétaitidentiquedanslesdeux groupes(29%vs20,5%;p=0,1181).Letauxderéhospitalisationétaitidentiquedanslesdeux groupes(0,8vs 0,9%,p=1).Lesfacteursderisquedecomplicationspostopératoireétaient l’absencedeSDJpréopératoire,l’expérienceduchirurgienetl’utilisationd’unegained’accès.

Conclusion.—L’absencededrainagepostopératoireparSDJaprèsurétéroscopien’augmente paslerisquededouleursoudecomplications.Iln’estpassystématiqueencasd’intervention noncompliquée,pourdescalculscentimétriquesencasd’uretèrepréparé.

Niveaudepreuve.— 3.

©2019Publi´eparElsevierMassonSAS.

Introduction

Managementofrenalsandureteralsstoneschangedalotin thepastfewyears.Technicalimprovementsaswellasendo- scopesminiaturizationandbetterdeflectionhaveledtoan increaseduseofureteroscopy(URS).AccordingtotheEuro- pean Association of Urology (EAU), flexible ureteroscopy (fURS)isnowrecommendedinfirstlinetreatmentforrenal stoneinferior to20mm.Itisalsoavailable forlowerpole renal calculi with unfavorable factor for extracorporeal shockwave lithotripsy (ESWL). URS is also recommended as second line treatment for renal stone superior to 20mm[1].

Double J stenting (DJS) after URS is still debated betweenurologists[2,3].Inthelasteditionoftheurolithi- asis EAU recommendation, stenting after URS is not mandatory in uncomplicated URS with complete stone removal.

DJSafterURSisusedtopreventriskofobstructionresul- ting from a residualfragment or postoperative edema. It may also reduce postoperative ureteral stenosis. Risk of ureteral stenosis after ureteroscopy is estimated at 1%.

It is higher in case of prolonged operative time, uretero- scope’sdiametergreaterthan9.5F,ureteralperforationor impacted calculi[4] andmaygounnoticedwithrepercus- sionsonrenalfunction[5].However,thosedevicesarenot insignificantandpatient’slifequalitycanbeaffectedwith clinical symptoms like urgency, hematuriaand social and sexualrepercussions.In2003,Joshietal.reported80%of stent-related painwithdailydisruptionofdaily activities, 80% of urinary symptoms and 32% of sexual dysfunction.

Other studies revealed,between 50 and80% of morbidity [6,7].

Further, stent migration, encrustation, pyelonephritis and forgotten stent can occur after stent placement [8].

Consequently, DJS after URS is still debated among the

(3)

urologist[2,3].Inourstudy,weassessedifureteralstenting withdoubleJmodifypainamongpatientsafterURS.Wealso searchforrisksofcomplications.

Methods

We retrospectivelyincluded every URSbetween May2014 andJanuary2017forureteraland/orrenalstone.Patients were eighteen years old or older. Interventions were excludedifthefollowupwasmadeinanothercenterorif drainageoftheupperurinarytractwasmadewithaureteral catheter.Urine sterilitywascontrolledbeforeeveryinter- vention and antibiotics were given if necessary. Patients received general anesthesia and prophylactic antibiotics during anesthesiainduction. fURS were performed with a 7,5FrKarlStorzendoscopeandsemirigidwitha7Fr Karl Storzuretero-renoscope.A0.035inchstiffterumosecurity wireandanaccesssheath(FlexorUreteralAccess Sheath) wereusedatthesurgeondiscretion.Positionwascontrolled usingfluoroscopy.AholmiumlaserYAG(DornierMedilasH20) wasusedforstonefragmentation(200to550umfiber)and abasketforstoneevacuationifnecessary.Everyprocedure lasted90minutesorlesstominimizecomplications.Atthe end,24cmand7FrsiliconeDJSwasusedaccordingtothe operator. The stent was removed 1 to 4weeks after the intervention,inconsultationunderlocalanesthesia,ordur- ingthenextprocedure.Eachpatientreceivednon-steroidal anti-inflammatory drug (NSAID) after the intervention for 3days.ThirteensurgeonsperformedURSandwerecatego- rized between twogroups, junior or senior. Seniors were titularsurgeonsandjunior,oneortwoyearsaftergradua- tion.Dataprotectioncommissionandethiccomityapproved thestudy.Pre-stentingwasusedincaseofemergencyorif renalaccesswasnotpossibleinapriorintervention.

Pain wasevaluated using Verbal Rating Scale (VRS). A telephone interview was conducted on day one for out- patientsurgery;otherwise,thenurseusedVRSduring the hospitalization.

Our primary outcomes were postoperative pain and postoperative complications. Patient’s data included age, gender, body mass index (BMI) and American Society of Anesthesiologists(ASA)score.Surgicaldata includedpres- enceofpreoperativestent,useofureteralaccesssheath, stonefreestatusbasedonpreoperativevieworrenalultra- sound or CT scan at 3months, stone location, surgeon’s experience,lengthofhospitalizationandoutpatientsurgery status. Stone dimensions were measured witha CT scan;

stoneburdenwasevaluatedwiththebiggeststonesizeand thecumulativesize.Complicationswererecordedaccording toClavien—Dindoclassification[9].Bothgroupswerecom- pared onthe basis of these parameters. We also made a multivariate regression analysistohighlight complications factors.

Statistical analysis

Patients characteristics were summarized as counts (frequencies) for qualitative variables and with a mean±standard deviation or median — [inter-quartile range(IQR)],asappropriate,forcontinuousvariables.

PatientscharacteristicswerecomparedusingtheFisher orChi2testforcategoricalvariablesandwithMann—Whitney forcontinuousvariables,asappropriate.

Alogisticregressionwasperformedtofindcomplications factorsandvalidated,withmanualbackwardvariableselec- tionprocess.Thisanalysisisconductedtoidentifypotential riskfactors.

Alltestswerebilateral,withatypeIerrorrateof5%.

The statistical analysis wasperformed using Graphpad Prism6.0andRsoftwareversion3.4.1.

Results Population

We included 366 interventions, 259 with a DJS and 107 without. Age, BMI, ASA score and gender were similar in both groups (Table 1). Maximum stone size was sig- nificantly higher in stented group (12.7±12.9mm versus 7.2±2.5mm;P<0.001).Cumulativestonesizewasalsosig- nificantlyslightly higher in stentedgroup (18.3±14.9mm versus9.4±5.2mm;P<0.001).Patientstreatedfor renals stones used to have significantly more DJS (68.78% ver- sus44%;P<0.001). Also,tubelesspatients benefited form ureteralpreparationsignificantlymoreoften beforeinter- vention(78.50%versus62.55%;P=0.004).

Table 2 shows peroperative data. fURS was significan- tly higher in stented group (58.69% interventions versus 36.45%; P<0.001) and significantly more access sheaths were employed (73.6% versus 42.4% P<0.001). Surgeon’s experiencedidnotchangepostoperativedrainage(43.63%

versus 48.60%; P=0.4512). Significantly more outpatient procedureswererealizedinnon-stentedgroup(75.7%versus 52.51%;P<0.001)andpatientshadsignificantlylessresidu- alsfragments(89%versus62.5%;P<0.001).Lengthofstay was slightly longer in stented group (1.23days versus 1;

P=0.222).

Postoperative pain

No differences were found regarding postoperative pain, 22% patients in the stented group suffered pain versus 17.75%(P=0.338)intubelessgroup.AlsotheVRS wasnot significantlydifferentamongpainfulpatients.

In fURSsubgroup, (Table 3),thoseresults were similar withnodifferencesonpainandcomplications.Also,patients withoutDJShadfewerresidualsfragmentsandweremore ambulatory.

Postoperative complication

Wedidnothighlightdifferencesincomplications(29%versus 20,5%,P=0.1181)(Table4).More patientshadpostopera- tivefever(18.6% versus9%)in DJSgroupandhadgrade2 complications (7.7%versus 1.9%).One patientin tubeless group needed an early reintervention for double J stent- ing because of an obstructive pyelonephritis. Another in stented group needed an early fibroscopy 48hours after ureteroscopy for double J ablation due to intense pain andoneneededanephrostomyunderlocalanesthesiafor a ureteral wound with an urinoma. One patient in each

(4)

Table1 Demographicdataandstonesparameters(n=366).

DoubleJstent(n=259) NodoubleJstent(n=107) P-value

Age(years)a 56.12±17.2(18—93) 54.7±16.3(20—91) 0.469

Gendermale/females(ratio) 1.76 1.56 0.679

ASA(n,%) 0.044

1 90(36.14) 46(51.11)

2 113(45.38) 36(40)

3 43(17.27) 8(8.89)

4 3(1.2) 0(0)

BMI(kg/m2)a 27.2±6.36(16—52.5) 26.54±4.98(17.6—42.9) 0.637

Maximumstonesize(mm)a 12.7±12.9(2—90) 7.2±2.5(3—16) <0.001

Cumulativestonesize(mm)a 18.3±14.9(2—90) 9.4±5.2(3—30) <0.001

Stonelocation(n,%) <0.001

Kidney 271(68.8) 56(44)

Uppercalix 48(17.7) 5(8.9)

Middlecalix 69(25.5) 19(33.9)

Lowercalix 91(33.6) 22(39.3)

Pyelic 63(23.2) 10(17.9)

Ureter 123(31.2) 74(56)

Proximal 89(72.35) 54(73)

Distal 34(27.65) 20(27)

Pre-stentureter(n,%) 162(62.5) 84(78.5) 0.004

ASA:AmericanSocietyofAnesthesiologists;BMI:bodymassindex.P-valuesignificant(i.e.,<0.05)indicatedinbold.

aMean±standarddeviation(range).

Table2 Operativedatacharacteristics(n=366).

DoubleJstent(n=259) Nostent(n=107) P-value

Accesssheath(n,%) 190(73.4) 45(42.1) <0.0001

Intervention(n,%) <0.0001

Flexible 152(58.7) 39(36.4)

Semirigid 61(23.5) 54(50.5)

Both 46(17.8) 14(13.1)

Surgeon(n,%) 0.4512

Junior 113(43.6) 52(48.6)

Senior 146(56.4) 55(51.4)

Stonefree(n,%) 160(62.5) 89(89) <0.0001

Ambulatory(n,%) 136(52.5) 81(75.7) <0.0001

Hospitalizationlength(days)a 1.29±1.2(1—11) 1±0.27(1—2) 0.222

P-valuesignificant(i.e.,<0.05)indicatedinbold.

aMean±standarddeviation(range).

grouphadhematuriawitch neededurethral stenting.One patient suffered from a sub capsular renal hematoma.

Patients without DJS did not have more unplanned admissions.

Inanotheranalysis,presentedureterswerelesspainful (Table5)andaccesssheathwouldcausemorepain.

Thoseresultswereconfirmedinamultivariateanalysis, (Tables6Aand6B)unpreparedureterandexperiencedsur- geons were more likely tohave complications (P=0.0042 and P=0.0381), so is access sheath (P=0.0334). Oth- erwise, DJS, ambulatory status, age, stone diameter and stone localization were not associated with higher risks.

Discussion

OurstudyrevealsthatureteralstentafterURSisnotalways necessary.Bothgroupswerenotsimilar;DJSgrouphadbig- gerstoneburdenandlesspre-stentureter.Wecannotcertify thatnotstentinginthispopulationwillnotincreasepainor complications.

Preparing ureterwith a DJS beforeURS may increases postoperative sepsis [10]. As shown in Assimos et al.’s study, it may be interesting to systematically implement a DJS preoperatively. They highlight that DJS before URS increasesstonefreeratesanddecreasescomplicationsfor renal stones [11].Nevertheless, this would requirea first

(5)

Table3 fURSsubgroupanalysis(n=191).

DoubleJstent(n=152) NodoubleJstent(n=39) P-value

Maximumstonesize(mm)a 10±14.61(2—90) 7±3.08(3—16) <0.001

Cumulativestonesize(mm)a 18±16.12(2—90) 10±6.28(5—30) <0.001

Pre-stentureter(n,%) 93(61.18) 25(64.10) 0.88

Accesssheath(n,%) 148(97.37) 35(89.74) 0.056

Stonefree(n,%) 77(50.66) 30(76.92) 0.005

Ambulatory(n,%) 72(47.37) 30(76.92) 0.001

Pain(n,%) 37(24.34) 12(30.77) 0.538

VRSa 4±2.16 5±2.4 0.611

Complications(n,%) 46(30.26) 14(35.90) 0.552

Clavien1 32(69.57) 12(85.71)

Clavien2 12(26.09) 2(14.29)

Clavien3a 1(2.17) 0

Clavien3b 1(2.17) 0

fURS:flexibleureteroscopy;VRS:VerbalRatingScale.P-valuesignificant(i.e.,<0.05)indicatedinbold.

a Mean±standarddeviation(range).

Table4 Painandcomplicationscharacteristics(n=366).

DoubleJstent Nostent P-value

Pain(n,%) 57(22) 19(17.7) 0.338

VRSa 4.48±2.32 4.8±2.14 0.4450

Complications(n,%) 75(29) 22(20.5) 0.1181

Clavien1 53(20.5) 19(17.7) 0.17

Clavien2 20(7.7) 2(1.9) 0.145

Clavien3a 1(0.4) 0 0.5

Clavien3b 1(0.4) 1(0.9) 0.5

Pain(n,%) 57(76) 19(86.4) 0.3979

Fever(n,%) 14(18.6) 2(9) 0.1664

Hematuria(n,%) 1(1.3) 1(4.5) 0.4998

Urinoma(n,%) 2(2.6) 0 1

Hematoma(n,%) 1(1.3) 0 1

Rehospitalization(n,%) 9(3.5) 3(2.8) 1

VRS:VerbalRatingScale.P-valuesignificant(i.e.,<0.05)indicatedinbold.

a Mean±standarddeviation.

interventionwithanesthesiaandcannotbefeasibleinrou- tine.

Moststudiesevaluatingpostoperativedrainagewereper- formedwithpatientstreatedforureteralstones.Songetal.

in 2011 conducted a meta-analysis including 15 studies with 1496 patients. Their conclusions were that ureteral drainageshouldnotbeusedsystematicallyaftersemirigid URS. Regarding postoperative pain, patients without DJS werelesspainful.Resultsaresimilarforlowerurinarytract symptoms(LUTS)withincreasedriskofdysuriaorurgencyin DJSgroup.Therewasnodifferencesinpersistentfragments, stenosisrisk,feverandemergencyconsultationsrates[12].

TherearefewstudiesonpostoperativestentafterfURS.

Torricelli et al. in 2014 conducted a retrospective study comparingDJSdrainageinpatientstreatedwithfURSusing an accesssheath. Their main outcomeswere pain evalu- ated with a visual analogue pain scale and postoperative complications.PatientswithoutDJSwerestatisticallymore

painfulandweremorelikelytoneedemergencyroomcare.

There were no differences regarding complications. In a subgroupanalysis,theyalsoshowedthatpatients without DJSand without prepared ureter weremore painful than patientswithpreparedureter.Theyconcludedthatpostop- erativestentwithDJSreducespainbutmaybeoptionalin caseofpreoperativeureteralpreparationbyDJS[13].

Recently,aprospectivemulticenterstudy,accomplished by the Clinical Research Office of Endourological Society included10,437patientswhoprofitfromafURSorasemi- rigid URS for renal or ureteral stones. The aim was to evaluaterisksandbenefitsofureteraldrainage.Forureteral calculi,postoperativestentsdecreasedbothdurationofhos- pitalstayandcomplications.Intheotherhand,therewas morerehospitalizations.Forrenalcalculi,patientswithDJS hadalsofewercomplications.Inthisstudy,theDJSpostop- erativeratewas60%aftersemirigidURSand80%afterfURS.

Complicationsrateswere1.4%forureteralsstoneswithDJS

(6)

Table5 Postoperativepainrisksfactors(n=366).

Pain (n=85)

Painless (n=281)

P-value

Age(years)a 55.64±13.34

(20—89)

57.72±17.16 (21—94)

0.312

Ambulatory(n,%) 55

(64.70)

162 (57.65)

0.301

DoubleJstent(n,%) 64

(75.29)

195 (69.39)

0.361

Pre-stentureter(n,%) 44

(51.76)

202 (71.88)

0.0008

Maximumstonesize(mm)a 9.79±4.27

(3—20)

11.29±11.52 (2—90)

0.067 Cumulativestonesize(mm)a 15.22±10.02

(3—60)

15.75±13.57 (2—90)

0.695

Accesssheath(n,%) 64

(75.29)

173 (61.56)

0.028

aMean±standarddeviation(range).P-valuesignificant(i.e.,<0.05)indicatedinbold.

Table6A Univariatelogisticregressionmodelsexaminingthepostoperativecomplications(n=366).

Complications(n=97) Nocomplication(n=269) P-value

Age(years)a 54.45±16.72(19—88) 56.66±16.99(18—93) 0.2992

Ambulatory(n,%) 62(63.92) 155(57.62) 0.3349

DoubleJstent(n,%) 75(77.31) 184(68.40) 0.1181

ASA(n,%) 0.4237

1 38(39.17) 98(36.43)

2 42(43.3) 117(43.49)

3 12(12.37) 39(14.49)

4 2(2.06) 1(0.37)

Lowercalixlocalization(n,%) 35(36.08) 78(29.00) 0.2021

Pre-stentureter(n,%) 53(54.64) 193(71.75) 0.0025

Maximumstonesize(mm)a 9.686±4.337(2—20) 11.57±12.76(3—90) 0.8517 Cumulativestonesize(mm)a 15.40±10.17(2—60) 15.86±14.51(3—90) 0.3579

Accesssheath(n,%) 73(75.26) 162(60.22) 0.0093

Surgeon(n,%) 0.0172

Junior 43(44.33) 158(58.74)

Senior 54(55.67) 111(41.26)

ASA:AmericanSocietyofAnesthesiologists.P-valuesignificant(i.e.,<0.05)indicatedinbold.

aMean±standarddeviation(range).

Table6B Multivariate(B)logisticregressionmodelsexaminingthepostoperativecomplications(n=366).

OR 95%CI P-value

DoubleJstent 0.7214 [0.3924—1.2964] 0.28

Ambulatory 0.6532 [0.3890—1.0823] 0.102

Unpre-stentureter 2.07 [1.2569—3.4113] 0.0042

Noaccesssheath 0.5427 [0.3048—0.9436] 0.0334

Senior 1.6781 [1.03—2.7459] 0.0381

OR:oddsratio;CI:confidenceinterval.P-valuesignificant(i.e.,<0.05)indicatedinbold.

Multivariateanalysis.

(7)

and 1.3% without. They were 4.1% and 10.2% for renals stones.Thoseratesaresimilartoours.Inthisstudy,post- operativedrainagebyDJSreducednumberofcomplications afterURS[14].

In our study, to minimize ureteral edema, patients receivedNSAIDsforafewdaysaftertheintervention.This mayexplainthedissonancewiththepreviousstudy.Despite NSAIDs,wedonotfindmoresepticscomplications.

Inaddition,outpatientsurgeryis nowproperlycodified andsupervised. It seemsfeasible without adding risksfor thepatient.ThisisconsistentwithOitchayomietal.study in2016.Theyfound6%ofcomplicationswithanambulatory loadfailurerateof2.2%with100patientsincluded[15].

Inaddition,URSdevelopmentwithfewercomplications thanpercutaneousnephrolithotomyleadsustotreatmore andmorevoluminouscalculi.

We didnotinvestigateDJS impactonLUTS.Itmust be consideredbeforestentingastheycanalterqualityoflife andsexualactivity[6,7].Bisioetal.evaluatedstent-related symptoms after semirigid URS and fURS. They used the Ureteric Stent Symptoms Questionnaire (USSQ).Two hun- dredandthirty-twopatientscompletedtheUSSQ.Theyhad 86.6% of urgency and 82.3% of burning mictions. Urinary tractsymptomswerea problemfor88.4% ofpatients and pain disturb life patients in 92.2%. More than 50% were unhappywith thestent. Beforeusing ureteralstent after URS, urologist should wisely think of consequences and inform patients of secondary effects [16]. It is also nec- essary to keep in mind necessity of stent removal under localanesthesiabyfibroscopy.Itincreasecostsandmaybe responsible of infections or pain. To overcomethis, using DJSwithextractorwirecanbeanalternative.Patientscan thenremovestents athomealoneor withanurseor dur- ingasimpleconsultation.Arecentmeta-analysiscompares regularDJSandwiredDJS.Patient’smajoritywereableto withdrawtheirstentathome(97%)andwassatisfied(75%).

Theywerealsolesspainfulthanduringcystoscopicablation.

MainriskofwiredDJSwasprematureremoval(10%),butit didnotincreasedcomplications[17].Thistechniquecanbe intendedinchosenpatients,afterclearinformation.

Ourstudy islimitedbecauseitis aretrospective mono centricstudy.WeanalyzedsemirigidURSandfURStomain- tainimportantpopulations.Thisisresponsibleofdisparate groupsbutweconsiderthatitdoesnotimpactpostoperative pain or our results. Furthermore, despite the large num- ber of surgeons, procedures are standardized, decreasing inter-operatorvariability.

Conclusion

Notstentingafterureteroscopyseemstobesafeforpatients withcentimeterstonesandpreparedureter.Usinganaccess sheathandlackofpreoperativestentingmayimpactpost- operativepainandcomplications.Outpatientsurgeryshould beconsideredassoonaspossible.

Disclosure of interest

Theauthorsdeclarethattheyhavenocompetinginterest.

References

[1]C. Türk, A. Skolarikos, A. Neisius, A. and al : EAU Guidelines on Urolithiasis. 2019. Available at https://

uroweb.org/guideline/urolithiasis.

[2]ForemanD,Plagakis S,Fuller AT.Should we routinely stent afterureteropyeloscopy?BJUInt2014;114:6—8.

[3]KeeleyFX,TimoneyAG.Routinestentingafterureteroscopy:

thinkagain.EurUrol2007;52(3):642—4.

[4]Johnson DB, PearleMS.Complicationsof ureteroscopy.Urol ClinNorthAm2004;31(1):157—71.

[5]Weizer AZ,AugeBK,SilversteinAD,DelvecchioFC,Brizuela RM,DahmP,etal.Routinepostoperativeimagingisimportant afterureteroscopic stone manipulation.JUrol 2002;168(1):

46—50.

[6]ByrneRR,AugeBK,KourambasJ,MunverR,DelvecchioF,Pre- minger GM.Routineureteral stentingis notnecessary after ureteroscopy and ureteropyeloscopy: a randomized trial. J Endourol2002;16(1):9—13.

[7]JoshiHB,StainthorpeA,MacDonaghRP,KeeleyFX,TimoneyAG, BarryMJ.Indwellingureteralstents:evaluationofsymptoms, qualityoflifeandutility.JUrol2003;169(3):1065—9[discussion 1069].

[8]Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN.

Severelyencrustedpolyurethaneureteralstents:management and analysis of potential risk factors. Urology 2001;58(4):

526—31.

[9]Dindo D, Demartines N, Clavien P-A. Classification of sur- gical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205—13.

[10]NevoA,ManoR,BanielJ,LifshitzDA.Uretericstentdwelling time: a risk factor for post-ureteroscopy sepsis. BJU Int 2017;120(1):117—22.

[11]Assimos D,Crisci A, Culkin D, XueW, RoelofsA, Duvdevani M, et al. Preoperative JJ stent placement in ureteric and renalstonetreatment:resultsfromtheClinicalResearchOffice ofEndourologicalSociety(CROES)ureteroscopy(URS)Global Study.BJUInt,2015;117(4):648—54.

[12]SongT,LiaoB,ZhengS,WeiQ.Meta-analysisofpostoperatively stentingornotinpatientsunderwentureteroscopiclithotripsy.

UrolRes2012;40(1):67—77.

[13]Torricelli FC, De S, Hinck B, Noble M, Monga M. Flexible ureteroscopywith aureteral access sheath: when tostent?

Urology2014;83(2):278—81.

[14]MuslumanogluAY,FuglsigS,FrattiniA,LabateG,NadlerRB, MartovA,etal.RisksandbenefitsofpostoperativedoubleJ stentplacementafterureteroscopy:resultsfromtheClinical ResearchOfficeofEndourologicalSocietyUreteroscopyGlobal Study.JEndourol2017;31(5):446—51.

[15]BosioA, AlessandriaE,Dalmasso E,PerettiD,AgostiS, Bis- contiA,etal.Howbothersomedouble-Jureteral stentsare aftersemirigidandflexibleureteroscopy:aprospectivesingle- institutionobservational study.WorldJUrol 2016;37:201—7.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731933/.

[16]BosioA, AlessandriaE,Dalmasso E,PerettiD,AgostiS, Bis- conti A, et al. How bothersome double-J ureteral stents are after semirigid and flexible ureteroscopy: a prospec- tive single-institution observational study. World J Urol 2018.

[17]OliverR,WellsH,TraxerO,KnollT,AboumarzoukO,BiyaniCS, etal.Uretericstentsonextractionstrings:asystematicreview ofliterature.Urolithiasis2018;46(2):129—36.

Références

Documents relatifs

Suite à la phase I de l’étude CheckMate-016 montrant un taux de survie globale à 2 ans de 67,3 % dans le bras du nivolumab 3 mg/kg plus ipilimumab 1 mg/kg (N3 + I1), et de 69,6 %

Le succès étant défini comme l’absence de fragment lithiasique résiduel (stone-free [SF]), l’évaluation précise de la charge lithiasique, historiquement évaluée par la mesure

Nous avons évalué la prévalence des patients sondés par service (répartis en secteur chirurgical ou médical), les indi- cations initiales du SV et de son maintien, la durée de

La population des 75 patients a été divisée en deux groupes distincts : le groupe 1, comprenant 39 patients chez qui ont été mises en place des sondes double J au cours

Le traitement par photothérapie dynamique à visée vas- culaire ou vascular-targeted photodynamic therapy (VTP) avec le WST11 est une option de traitement focal en cours

Montant: 43 590,63$/patiente 10 janvier 2020 – en cours PROVENCHER, DIANE Réseau de recherche sur le cancer Chercheure principale: Mes-Masson AM. Co-investigateurs: Bachvarov

Dès lors, le sac de couchage est dorénavant obligatoire dans votre sac suiveur pour vous permettre de dormir dans les bases de vie.. Le sac à viande est autorisé mais

Je tiens tout d’abord à remercier la Société Française de Spectrométrie de Masse (SFSM) pour m’avoir accordé une bourse me permettant de participer au 35 th congrès annuel